PTH ETF holdings
Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.
| Snapshot field | Reported value |
|---|
| Fund | Invesco Dorsey Wright Healthcare Momentum ETF |
|---|
| Report date | 2026-04-30 |
|---|
| Reported holdings | 61 |
|---|
| SEC series ID | S000013104 |
|---|
Positions 1–61 of 61
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|
| Invesco Private Prime Fund | Invesco Private Prime Fund | 22.917417% | 27,709,108.6338 | 27,706,338 NS |
|---|
| Invesco Private Government Fund | Invesco Private Government Fund | 8.829121% | 10,675,159.86 | 10,675,159.86 NS |
|---|
| PRAX | Praxis Precision Medicines, Inc. | 5.080616% | 6,142,897.61 | 19,267 NS |
|---|
| ROIV | Roivant Sciences Ltd. | 4.650817% | 5,623,234.47 | 197,099 NS |
|---|
| UTHR | United Therapeutics Corp. | 3.434474% | 4,152,571.8 | 7,268 NS |
|---|
| THC | Tenet Healthcare Corp. | 3.038954% | 3,674,354.4 | 20,745 NS |
|---|
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | 2.861608% | 3,459,928.24 | 65,368 NS |
|---|
| TNGX | Tango Therapeutics Inc. | 2.851887% | 3,448,173.8 | 159,490 NS |
|---|
| HCA | HCA Healthcare, Inc. | 2.776835% | 3,357,429.6 | 7,728 NS |
|---|
| AXSM | Axsome Therapeutics, Inc. | 2.643514% | 3,196,233.75 | 15,385 NS |
|---|
| NKTR | Nektar Therapeutics | 2.572121% | 3,109,912.8 | 36,570 NS |
|---|
| CELC | Celcuity Inc. | 2.527395% | 3,055,835.7 | 25,182 NS |
|---|
| IONS | Ionis Pharmaceuticals, Inc. | 2.373973% | 2,870,335.44 | 38,394 NS |
|---|
| CAPR | Capricor Therapeutics, Inc. | 2.260783% | 2,733,479.16 | 81,402 NS |
|---|
| COR | Cencora, Inc. | 2.249155% | 2,719,420.29 | 8,829 NS |
|---|
| ALMS | Alumis Inc. | 2.121108% | 2,564,599.68 | 103,872 NS |
|---|
| GILD | Gilead Sciences, Inc. | 1.987135% | 2,402,614.92 | 18,363 NS |
|---|
| KOD | Kodiak Sciences Inc. | 1.985878% | 2,401,096.04 | 55,223 NS |
|---|
| BrightSpring Health Services, Inc. | BrightSpring Health Services, Inc. | 1.976788% | 2,390,105.25 | 49,825 NS |
|---|
| JAZZ | Jazz Pharmaceuticals PLC | 1.918563% | 2,319,706.52 | 11,426 NS |
|---|
| MRNA | Moderna, Inc. | 1.902823% | 2,300,675.2 | 50,080 NS |
|---|
| PTGX | Protagonist Therapeutics, Inc. | 1.896177% | 2,292,640.05 | 23,165 NS |
|---|
| VTRS | Viatris Inc. | 1.878279% | 2,270,999.52 | 152,008 NS |
|---|
| DNTH | Dianthus Therapeutics, Inc. | 1.795525% | 2,170,942.8 | 24,726 NS |
|---|
| ANAB | AnaptysBio, Inc. | 1.778119% | 2,149,896.84 | 32,708 NS |
|---|
| ENSG | Ensign Group, Inc. (The) | 1.732898% | 2,095,221.87 | 11,223 NS |
|---|
| INCY | Incyte Corp. | 1.714818% | 2,073,361.01 | 21,763 NS |
|---|
| ERAS | Erasca, Inc. | 1.709658% | 2,067,122.4 | 194,096 NS |
|---|
| Ligand Pharmaceuticals Inc. | Ligand Pharmaceuticals Inc. | 1.616854% | 1,954,914 | 8,520 NS |
|---|
| ORKA | Oruka Therapeutics, Inc. | 1.602514% | 1,937,576.43 | 28,323 NS |
|---|
| CGON | CG Oncology, Inc. | 1.551913% | 1,876,395.1 | 28,115 NS |
|---|
| TYRA | Tyra Biosciences, Inc. | 1.540245% | 1,862,287.25 | 53,591 NS |
|---|
| SLS | SELLAS Life Sciences Group, Inc. | 1.503384% | 1,817,719.2 | 367,216 NS |
|---|
| SYRE | Spyre Therapeutics, Inc. | 1.485201% | 1,795,734 | 24,120 NS |
|---|
| KYMR | Kymera Therapeutics, Inc. | 1.464052% | 1,770,163.45 | 21,835 NS |
|---|
| TWST | Twist Bioscience Corp. | 1.453364% | 1,757,240.8 | 30,064 NS |
|---|
| LQDA | Liquidia Corp. | 1.416293% | 1,712,418.33 | 43,673 NS |
|---|
| BKD | Brookdale Senior Living Inc. | 1.412419% | 1,707,734.28 | 118,923 NS |
|---|
| AXGN | Axogen, Inc. | 1.368797% | 1,654,992 | 38,310 NS |
|---|
| EXEL | Exelixis, Inc. | 1.333007% | 1,611,719.46 | 36,251 NS |
|---|
| EWTX | Edgewise Therapeutics, Inc. | 1.311265% | 1,585,430.64 | 51,209 NS |
|---|
| TRVI | Trevi Therapeutics, Inc. | 1.298675% | 1,570,208.64 | 114,114 NS |
|---|
| CYTK | Cytokinetics, Inc. | 1.188256% | 1,436,702.23 | 22,459 NS |
|---|
| ELAN | Elanco Animal Health Inc. | 1.164694% | 1,408,213.87 | 62,951 NS |
|---|
| RLAY | Relay Therapeutics, Inc. | 1.131632% | 1,368,239.04 | 105,574 NS |
|---|
| DYN | Dyne Therapeutics, Inc. | 1.12286% | 1,357,632.9 | 77,358 NS |
|---|
| PCVX | Vaxcyte, Inc. | 1.120244% | 1,354,470.12 | 23,663 NS |
|---|
| KRYS | Krystal Biotech, Inc. | 1.100373% | 1,330,444.98 | 5,073 NS |
|---|
| ELVN | Enliven Therapeutics, Inc. | 1.068801% | 1,292,271.89 | 31,343 NS |
|---|
| RCUS | Arcus Biosciences, Inc. | 0.942421% | 1,139,467.5 | 44,685 NS |
|---|
| ANNX | Annexon, Inc. | 0.917243% | 1,109,024.97 | 188,931 NS |
|---|
| STOK | Stoke Therapeutics, Inc. | 0.912388% | 1,103,154.8 | 33,715 NS |
|---|
| PAHC | Phibro Animal Health Corp. | 0.903644% | 1,092,583.1 | 20,545 NS |
|---|
| MLTX | MoonLake Immunotherapeutics | 0.786984% | 951,530.58 | 58,091 NS |
|---|
| BIOA | BioAge Labs, Inc. | 0.771324% | 932,596.95 | 55,347 NS |
|---|
| SNDX | Syndax Pharmaceuticals, Inc. | 0.72692% | 878,908.59 | 41,013 NS |
|---|
| CATX | Perspective Therapeutics Inc. | 0.669214% | 809,136.9 | 207,471 NS |
|---|
| ZBIO | Zenas Biopharma, Inc. | 0.634064% | 766,636.92 | 39,681 NS |
|---|
| VRDN | Viridian Therapeutics, Inc. | 0.580848% | 702,294.52 | 52,099 NS |
|---|
| MAZE | Maze Therapeutics, Inc. | 0.507073% | 613,094.28 | 23,066 NS |
|---|
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio | 0.266512% | 322,235.69 | 322,235.69 NS |
|---|